InspireMD, Inc. (NSPR) stock
NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 10/3046% below fair value
$0.77−0.03 (-3.25%)
Close on Nov 12, 2026Market cap $35.98MP/E –Yield –
InspireMD gross margin
Gross margin is gross profit as a percentage of revenue.
InspireMD's gross margin for the twelve months ending Jun 30, 2026 was 18.1%. For fiscal 2025 it was 29.5%, against 21.5% the year before. The highest annual figure on record is 53.2% in fiscal 2013.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 29.5% | +8.0 |
| FY2024 | Dec 31, 2024 | 21.5% | −7.6 |
| FY2023 | Dec 31, 2023 | 29.1% | +7.5 |
| FY2022 | Dec 31, 2022 | 21.6% | +4.8 |
| FY2021 | Dec 31, 2021 | 16.8% | +13.4 |
| FY2020 | Dec 31, 2020 | 3.3% | −17.0 |
| FY2019 | Dec 31, 2019 | 20.3% | −7.3 |
| FY2018 | Dec 31, 2018 | 27.6% | +6.4 |
| FY2017 | Dec 31, 2017 | 21.2% | +15.8 |
| FY2016 | Dec 31, 2016 | 5.4% | +18.2 |
| FY2015 | Dec 31, 2015 | -12.8% | −66.0 |
| FY2013 | Jun 30, 2013 | 53.2% | +7.6 |
| FY2010 | Dec 31, 2010 | 45.5% | +12.7 |
| FY2009 | Dec 31, 2009 | 32.8% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -43.7% | −61.3 |
| Q1 FY2026 | Mar 31, 2026 | 20.2% | +1.1 |
| Q4 FY2025 | Dec 31, 2025 | 37.5% | +13.4 |
| Q3 FY2025 | Sep 30, 2025 | 34.2% | +11.4 |
| Q2 FY2025 | Jun 30, 2025 | 17.6% | −1.4 |
| Q1 FY2025 | Mar 31, 2025 | 19.1% | −0.2 |
| Q4 FY2024 | Dec 31, 2024 | 24.1% | −4.6 |
| Q3 FY2024 | Sep 30, 2024 | 22.9% | −5.3 |
| Q2 FY2024 | Jun 30, 2024 | 19.0% | −10.7 |
| Q1 FY2024 | Mar 31, 2024 | 19.3% | −10.8 |
| Q4 FY2023 | Dec 31, 2023 | 28.7% | +9.4 |
| Q3 FY2023 | Sep 30, 2023 | 28.1% | +2.6 |
| Q2 FY2023 | Jun 30, 2023 | 29.8% | +1.6 |
| Q1 FY2023 | Mar 31, 2023 | 30.1% | +19.8 |
| Q4 FY2022 | Dec 31, 2022 | 19.3% | −2.0 |
| Q3 FY2022 | Sep 30, 2022 | 25.6% | +17.0 |
| Q2 FY2022 | Jun 30, 2022 | 28.2% | +2.9 |
| Q1 FY2022 | Mar 31, 2022 | 10.3% | −0.2 |
| Q4 FY2021 | Dec 31, 2021 | 21.3% | +268.1 |
| Q3 FY2021 | Sep 30, 2021 | 8.6% | −21.8 |
| Q2 FY2021 | Jun 30, 2021 | 25.2% | +63.6 |
| Q1 FY2021 | Mar 31, 2021 | 10.5% | −18.0 |
| Q4 FY2020 | Dec 31, 2020 | -246.8% | −272.4 |
| Q3 FY2020 | Sep 30, 2020 | 30.4% | +16.8 |
| Q2 FY2020 | Jun 30, 2020 | -38.3% | −71.0 |
| Q1 FY2020 | Mar 31, 2020 | 28.5% | +46.1 |
| Q4 FY2019 | Dec 31, 2019 | 25.6% | −2.0 |
| Q3 FY2019 | Sep 30, 2019 | 13.6% | −12.1 |
| Q2 FY2019 | Jun 30, 2019 | 32.6% | +5.0 |
| Q1 FY2019 | Mar 31, 2019 | -17.6% | −46.7 |
| Q4 FY2018 | Dec 31, 2018 | 27.6% | +2.3 |
| Q3 FY2018 | Sep 30, 2018 | 25.7% | +4.4 |
| Q2 FY2018 | Jun 30, 2018 | 27.6% | +4.6 |
| Q1 FY2018 | Mar 31, 2018 | 29.1% | +16.1 |
| Q4 FY2017 | Dec 31, 2017 | 25.3% | +42.7 |
| Q3 FY2017 | Sep 30, 2017 | 21.3% | +14.9 |
| Q2 FY2017 | Jun 30, 2017 | 23.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 13.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -17.4% | – |
| Q3 FY2016 | Sep 30, 2016 | 6.4% | – |
See a number that looks wrong?